Free Trial

Coherus BioSciences (CHRS) Earnings Date, Estimates & Call Transcripts

Coherus BioSciences logo
$0.78 -0.04 (-4.89%)
(As of 11/13/2024 ET)

Coherus BioSciences Latest Earnings Summary

Upcoming Q3
Earnings Date
Mar. 12Estimated
Actual EPS
(Aug. 8)
-$0.20 Beat By $0.10
Consensus EPS
(Aug. 8)
-$0.30

Coherus BioSciences posted Q2 2024 earnings on August 8, 2024, reporting an EPS of -$0.20, which topped the consensus estimate of -$0.30 by $0.10. Quarterly revenue was reported to be $64.98 million, above analysts' expectations of $57.08 million. With a trailing EPS of -$0.08, Coherus BioSciences' earnings are expected to grow next year, from ($1.16) to ($0.85) per share.

CHRS Upcoming Earnings

Coherus BioSciences' next earnings date is estimated for Wednesday, March 12, 2025, based off prior year's reporting schedules.

Get Coherus BioSciences Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Coherus BioSciences and other key companies, straight to your inbox.

Sign Up
Skip Charts & View Estimated and Actual Earnings Data

CHRS Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

CHRS Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Coherus BioSciences Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q4 20241-$0.25-$0.25-$0.25

Coherus BioSciences Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueLinks
3/12/2025
(Estimated)
------- 
8/8/2024Q2 2024-$0.30-$0.20+$0.10-$0.29$57.08M$64.98M
5/9/2024Q1 2024-$0.05-$0.38 -$0.33-$1.59$102.00M$77.06M      
3/13/2024Q4 2023-$0.33-$0.72 -$0.39-$0.73$105.30M$91.52M  
11/6/2023Q3 2023-$0.45-$0.38+$0.07-$0.35$80.13M$74.57M  
8/2/2023Q2 2023-$0.66-$0.49+$0.17-$0.49$50.83M$58.72M  
5/8/2023Q1 2023-$0.77-$0.89 -$0.12-$0.82$50.73M$32.44M  
3/6/2023Q4 2022-$0.64-$0.76 -$0.12-$0.76$45.72M$45.35M    

Coherus BioSciences Earnings - Frequently Asked Questions

Coherus BioSciences has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, March 12th, 2025 based off last year's report dates. Learn more on CHRS's earnings history.

In the previous quarter, Coherus BioSciences (NASDAQ:CHRS) reported ($0.20) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.30) by $0.10. Learn more on analysts' earnings estimate vs. CHRS's actual earnings.

Coherus BioSciences (NASDAQ:CHRS) has a recorded annual revenue of $257.24 million.

Coherus BioSciences (NASDAQ:CHRS) has a recorded net income of -$237.89 million. CHRS has generated -$0.08 earnings per share over the last four quarters.

Coherus BioSciences's earnings are expected to grow from ($1.16) per share to ($0.85) per share in the next year.

`

More Earnings Resources from MarketBeat



This page (NASDAQ:CHRS) was last updated on 11/14/2024 by MarketBeat.com Staff
From Our Partners